Talk Digital Health Technologies track
Harnessing Digital Biomarkers and Data Science: Paving the Way for Accelerated Drug Development in Parkinson’s Disease
Tue, Feb 4, 2025 · 11:05–11:35 AM EST Rosen Shingle Creek
About this session
Digital biomarkers have the potential to track Parkinson’s Disease (PD) progression with increased objectivity, sensitivity, and reduced variability compared to standard clinical scales. We discuss considerations in the development of PD progression digital biomarkers and present a machine learning-based framework for developing composite digital measures. We apply this framework to longitudinal PD study data and demonstrate the potential for digital biomarkers to enable smaller PoC trials and accelerated drug development.
